Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pure erythroid leukemia is characterized by biallelic TP53 inactivation and abnormal p53 expression patterns in de novo and secondary cases.

Haematologica - 1 Sept 2022

Fang Hong, Wang Sa A, Khoury Joseph D, El Hussein Siba, Kim Do Hwan, Tashakori Mehrnoosh, Tang Zhenya, Li Shaoying, Hu Zhihong, Jelloul Fatima Zahra, Patel Keyur P, McDonnell Timothy J, Kadia Tapan, Medeiros L Jeffrey, Wang Wei

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Leukemia
Share to Mutation
Share to Tumor Suppressor Protein p53

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Open in PubMed Open full text

Identifiers

PMID: 35511670
DOI: 10.3324/haematol.2021.280487
PMCID: PMC9425316

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pure erythroid leukemia is characterized by biallelic TP53 inactivation and abnormal p53 expression patterns in de novo and secondary cases.PMID 35511670Read ↗

More than 1 TP53 abnormality is a dominant characteristic of pure erythroid leukemia.Semantic proximity Read ↗

Pure (acute) erythroid leukemia: morphology, immunophenotype, cytogenetics, mutations, treatment details, and survival data among 41 Mayo Clinic cases.Semantic proximity Read ↗

Differential characteristics of TP53 alterations in pure erythroid leukemia arising after exposure to cytotoxic therapy.Semantic proximity Read ↗

An unusual case of pure erythroid leukemia with normal karyotype and NPM1 mutation.Semantic proximity Read ↗

De novo pure erythroid leukemia: refining the clinicopathologic and cytogenetic characteristics of a rare entity.Semantic proximity Read ↗

A History and Current Understanding of Acute Erythroid Leukemia.Semantic proximity Read ↗

Acute Erythroid Leukemia: From Molecular Biology to Clinical Outcomes.Semantic proximity Read ↗

[Molecular pathogenesis and therapeutic targets in acute erythroid leukemia].Semantic proximity Read ↗

A rare de novo pure erythroid leukemia with JAK2 R683S mutation.Semantic proximity Read ↗

Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classification.Semantic proximity Read ↗

Amplified EPOR/JAK2 Genes Define a Unique Subtype of Acute Erythroid Leukemia.Semantic proximity Read ↗

Loss of BAP1 defines a unique subtype of TP53-mutated de novo AML and confers sensitivity to BCL-xL inhibitors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.